News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Biogen prices new MS drug at discount to key competitors

Started by riky, March 30, 2013, 08:00:20 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Biogen prices new MS drug at discount to key competitors

<p><a href="http://news.yahoo.com/biogen-prices-ms-drug-discount-key-competitors-180633956--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/hzJlT8eX50iitB4iVo99Tg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-29T180633Z_1_CBRE92S1EB000_RTROPTP_2_USA.JPG" width="130" height="86" alt="A pedestrian passes the sign outside the headquarters of Biogen Idec Inc. in Cambridge" align="left" title="A pedestrian passes the sign outside the headquarters of Biogen Idec Inc. in Cambridge" border="0" /></a>WASHINGTON (Reuters) - Biogen Idec Inc said on Friday it will charge $54,900 a year for its multiple sclerosis drug, Tecfidera, which received U.S. approval on Wednesday. The company has priced the drug at a discount to key competitors such as Novartis AG's MS pill Gilenya, which costs roughly $60,000 a year, in a bid to maximize its market share. &quot;We think this represents solid value to the MS community and demonstrates our commitment to patient access,&quot; said Kate Niazi-Sai, a Biogen spokeswoman. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login